Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice

European Journal of Neuroscience

Volumn 19, Issue 7, 2004, Pages 1906-1912

  Haller, J ^a   Varga, B ^a   Ledent, C ^b   Barna, I ^a   Freund, T F ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cannabinoids; Elevated plus maze; Knock out; Resident intruder; Social interaction

Indexed keywords

CANNABINOID 1 RECEPTOR;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; GENE DISRUPTION; GENOTYPE; KNOCKOUT MOUSE; MALE; MAZE TEST; MENTAL STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR GENE; SOCIAL BEHAVIOR; SOCIAL INTERACTION; SPECIES COMPARISON; SPECIES DIFFERENCE; STRAIN DIFFERENCE; WILD TYPE;

EID: 1842633508     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03293.x     Document Type: Article

References (52)

1. Akinshola, B.E., Chakrabarti, A. & Onaivi, E.S. (1999) In-vitro and in-vivo action of cannabinoids. Neurochem. Res., 24, 1233-1240.
2. Allison, K.R. & Dignam, C. (1990) Social and school factors in predicting cannabis use among Ontario high school students. Can. J. Public Health, 81. 301-306.
3. Barna, I., Acs, Z., Bugovics, G. & Koenig, J.I. (1995) Effect of interleukin-1 beta on plasma ACTH, beta-endorphin, and corticosterone levels in infant and prepubertal rats. Pediatr. Res., 37, 714-719.
4. 1A receptor agonist with anxiolytic activity. Eur. J. Pharmacol, 344, 127-135.
5. Boys, A., Marsden, J. & Strang, J. (2001) Understanding reasons for drug use amongst young people: a functional perspective. Health Educ. Res., 16. 457-469.
6. Breivogel, C.S., Griffin, G., Di Marzo, V. & Martin, B.R. (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol, 60, 155-163.
7. Capanna, E., Corti, M., Mainardi, D., Parmigiani, S. & Brain, P.P. (1984) Karyotype and intermale aggression in wild house mice: ecology and speciation. Behav. Genet., 14, 195-208.
8. Chaki, S., Kawashima, N., Suzuki, Y., Shimazaki, T. & Okuyama, S. (2003) Cocaine-and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents. Eur. J. Pharmacol., 464, 49-54.
9. Crawley, J.N. (1985) Exploratory behavior models of anxiety in mice. Neurosci. Biobehav. Rev., 9, 37-34.
10. Cruz-Morales, S.E., Santos, N.B. & Brandao, M.L. (2002) One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacol. Biochem. Behav., 72, 973-978.
11. Cutler, M.G. & Mackintosh, J.H. (1984) Cannabis and delta-9-tetrahydrocannabinol. Effects on elements of social behaviour in mice. Neuropharmacology, 23, 1091-1097.
12. Di, S., Malcher-Lopez, R., Halmos, K.C. & Tasker, J.G. (2003) Non-genomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feed-back mechanism. J. Neurosci., 23, 4850-4857.
13. Di Marzo, V., Breivogel, C.S., Tao, Q., Bridgen, D.T., Razdan, R.K., Zimmer, A.M., Zimmer, A. & Martin, B.R. (2000) Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J. Neurochem., 75, 2434-2444.
14. Dorr, M. & Steinberg, H. (1976) Effects of delta-9- tetrahydrocannabinol on social behaviour in mice: comparison between two vehicles. Psychopharmacology, 47, 87-91.
15. Fergusson, D.M., Horwood, L.J. &Swain-Campbell, N. (2002) Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction, 97, 1123-1135.
16. Ferrari, P.F., Palanza, P., Parmigiani, S. & Rodgers, R.J. (1998) Interindividual variability in Swiss male mice: relationship between social factors, aggression and anxiety. Physiol. Behav., 63, 821-827.
17. File, S.E. (1993) The interplay of learning and anxiety in the elevated plusmaze. Behav. Brain Res., 58, 199-202.
18. Foltin, R.W., Brady, J.V., Fischman, M.W., Emurian, C.S. & Dominitz, J. (1987) Effects of smoked marijuana on social interaction in small groups. Drug Alcohol Depend., 20, 87-93.
19. Foltin, R.W. & Fischman, M.W. (1988) Effects of smoked marijuana on human social behaviour in small groups. Pharmacol. Biochem. Behav., 30, 539-541.
20. de Fonseca, F.R., Rubio, P., Menzaghi, F., Merlo-Pich, E., Rivier, J., Koob, G.F. & Navarro, M. (1996) Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J. Pharmacol. Exp. Ther., 276, 56-64.
21. Griebel, G., Moreau, J.-L., Jenck, F., Martin, J.R. & Misslin, R. (1993) Some critical determinants of the behaviour of rats in the elevated plus-maze. Behav. Proc., 29, 37-48.
22. Hájos, N., Ledent, C. & Freund, T.F. (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience. 106, 1-4.
23. Haller, J., Bakos, N., Szirmay, M., Ledent, C. & Freund, T.F. (2002) The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur. J. Neurosci., 16, 1395-1399.
24. Haller, J., Makara, G.B. & Kovács, J.L. (1996) The effect of α2 adrenoceptor blockers on aggressive behavior in mice: implications for the action of adrenoceptor agents. Psychopharmacology, 126, 345-350.
25. Hogg, S. (1996) A review of the validity and variability of the elevated plusmaze as an animal model of anxiety. Pharmacol. Biochem. Behav., 54, 21-30.
26. Jarai, Z., Wagner, J.A., Varga, K., Lake, K.D., Compton, D.R., Martin, B.R., Zimmer, A.M., Bonner, T.I., Buckley, N.E., Mezey, E., Razdan, R.K., Zimmer, A. & Kunos, G. (1999) Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl Acad. Sci. USA, 96, 14136-14141.
27. Krsiak, M., Podhorná, J. & Miczek, K.A. (1998) Aggressive and social behavior after alprazolam withdrawal: experimental therapy with Ro 19-8022. Neurosci. Biobehav. Rev., 23, 155-161.
28. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.F., Beslot, F., Bohme, G.A., Imperato, A., Pedrazzini, T., Roques, B.P., Vassart, G., Fratta, W. & Parmentier, M. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 283, 401-404.
29. Makara, G.B. & Haller, J. (2001) Non-genomic effects of glucocorticoids in the neural system. Evidence, mechanisms and implications. Prog. Neurobiol., 65, 367-390.
30. Manzanares, J., Corchero, J. & Fuentes, J.A. (1999) Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats. Brain Res., 839, 173-179.
31. Martin, M., Ledent, C., Parmentier, M., Maldonado, R. & Valverde, O. (2002) Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology, 159, 379-387.
32. Mehndiratta, S.S. & Wig, N.N. (1975) Psychosocial effects of longterm cannabis use in India. A study of fifty heavy users and controls. Drug Alcohol Depend., 1, 71-81.
33. Miczek, K.A. (1978) Delta-9-tetrahydrocannabinol: antiaggressive effects in mice, rats and squirrel monkeys. Science, 199, 1459-1461.
34. Mikics, E., Kruk, M.R. & Haller, J. (2004) Genomic and non-genomic effects of glucocorticoids on aggressive behavior in male rats. Psychoneuroendocrinology, in press, doi: 10.1016/50306-4530(03) 00090-8.
35. Nakamura, K. & Kurasawa, M. (2001) Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism. Eur. J. Pharmacol., 420, 33-43.
36. Navarro, M., Hernandez, E., Munoz, R.M., del Arco, I., Villanua, M.A., Carrera, M.R. & Rodriguez de Fonseca, F. (1997) Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport, 8, 491-496.
37. Ogborne, A.C., Smart, R.G., Weber, T. & Birchmore-Timney, C. (2000) Who is using cannabis as a medicine and why: an exploratory study. J. Psychoactive Drugs, 32, 435-443.
38. Peralta, V. & Cuesta, M.J. (1992) Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr. Scand., 85, 127-130.
39. Podhorna, J. & Krsiak, M. (2000) Behavioural effects of a benzodiazepine receptor partial agonist, Ro 19-8022, in the social conflict test in mice. Behav. Pharmacol., 11, 143-151.
40. Poshivalov, V.P. (1980) The integrity of the social hierarchy in mice following administration of psychotropic drugs. Br. J. Pharmacol., 70, 367-373.
41. van Ree, J.M., Niesink, R.J. & Nir, I. (1984) Delta 1-tetrahydrocannabinol but not cannabidiol reduces contact and aggressive behaviour of rats tested in dyadic encounters. Psychopharmacology, 84, 561-575.
42. Rodgers, R.J., Haller, J., Halasz, J. & Mikics, E. (2003) 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze. Eur. J. Neurosci., 17, 1279-1286.
43. Rodgers, R.J., Haller, J., Holmes, A., Halasz, J., Walton, T. & Brain, P.F. (1999) Corticosterone response to the plus-maze: high correlations with risk assessment in rats and mice. Physiol. Behav., 68, 47-53.
44. Sethi, B.B., Trivedi, J.K., Kumar, P., Gulati, A., Agarwal, A.K. & Sethi, N. (1986) Antianxiety effect of cannabis: involvement of central benzodiazepine receptors. Biol. Psychiatry, 21, 3-10.
45. Sharma, B.P. (1975) Cannabis and its users in Nepal. Br. J. Psychiatry., 127, 550-552.
46. Sieber, B. (1982) Influence of hashish extract on the social behaviour of encountering male baboons (Papio c. anubis). Pharmacol. Biochem. Behav., 17, 209-216.
47. Spencer, C., Castle, D. & Michie, P.T. (2002) Motivations that maintain substance use among individuals with psychotic disorders. Schizophr. Bull. 28, 233-247.
48. Stewart, S.H., Karp, J., Pihl, R.O. & Peterson, R.A. (1997) Anxiety sensitivity and self-reported reasons for drug use. J. Subst. Abuse, 9, 223-240.
49. Tournier, M., Sorbara, F., Gindre, C., Swendsen, J.D. & Verdoux, H. (2003) Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population. Psychiatry Res., 118, 1-8.
50. Tunving, K. (1987) Psychiatric aspects of cannabis use in adolescents and young adults. Pediatrician, 14, 83-91.
51. Weidenfeld, J., Feldman, S. & Mechoulam, R. (1994) Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamopituitary-adrenal axis in the rat. Neuroendocrinology, 59, 110-112.
52. Zimmer, A., Zimmer, A.M., Hohmann, A.G., Herkenham, M. & Bonner, T.I. (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CBl receptor knockout mice. Proc. Natl Acad. Sci. USA, 96, 5780-5785.